Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +52.77%
#2 Pons Pons +45.08%
#3 TENDIES TENDIES +43.57%
#4 PondCoin PondCoin +39.77%
#5 Magma Finance Magma Finance +34.63%
#6 Purr Purr +32.38%
#7 StonkBroker StonkBroker +31.36%
#8 Ocean Protocol Ocean Protocol +28.98%
#9 SkyAI SkyAI +27.20%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.14%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Taiwan Advance Bio-Pharmaceutical Inc. Taiwan Advance Bio-Pharmaceutical Inc.

Taiwan Advance Bio-Pharmaceutical Inc.

4186
Classifica tra le azioni #29152
Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a... Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a substantial international presence, conducting operations across numerous countries such as China, Germany, the USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, and Pakistan, in addition to other global markets. Founded in 1989 and headquartered in New Taipei City, Taiwan, the company delivers a comprehensive array of products and services. Its offerings encompass diagnostic kits for ensuring food safety, alongside tailored customization services for ELISA, rapid, and chemical test kits, and expert consultation for setting up food safety laboratories. The firm also specializes in manufacturing both monoclonal and polyclonal antibody products. Furthermore, its portfolio includes rapid screening tests for illicit substances. It provides essential cell banking services for the secure preservation of both newborn and adult stem cells. The company also operates a dedicated drug testing facility, performing analyses on urine and hair samples to detect and identify drug abuse.
Prezzo delle azioni
$0.2518483
Capitalizzazione di mercato
$22.67M
Variazione (1 giorno)
-1.61%
Variazione (1 anno)
-31.34%
Paese
TW
Scambia Taiwan Advance Bio-Pharmaceutical Inc. (4186)

Categoria

Healthcare
Ricavi di Taiwan Advance Bio-Pharmaceutical Inc. (4186)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Taiwan Advance Bio-Pharmaceutical Inc., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Taiwan Advance Bio-Pharmaceutical Inc. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH